Do management hate shareholders that much that they would consider such a thing- If they did they should be out of a job and the industry ?The thought of handing data to big pharma in those circumstances - disaster. IMO breaking every common sense rule in the book and FTT aren't that sort of bucket shop.. How does that create competitive bidding?
for what purpose?, page-16
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
